SK284387B6 - Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom - Google Patents

Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom Download PDF

Info

Publication number
SK284387B6
SK284387B6 SK1385-2000A SK13852000A SK284387B6 SK 284387 B6 SK284387 B6 SK 284387B6 SK 13852000 A SK13852000 A SK 13852000A SK 284387 B6 SK284387 B6 SK 284387B6
Authority
SK
Slovakia
Prior art keywords
methoxy
phenyl
pyridyl
quinolizin
alkyl
Prior art date
Application number
SK1385-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK13852000A3 (sk
Inventor
Jean-Bernard Fourtillan
Marianne Fourtillan
Jean-Claude Jacquesy
Marie-Paule Jouannetaud
Bruno Violeau
Omar Karam
Original Assignee
Macef
Laboratoires Besins Iscovesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,990 external-priority patent/US6048868A/en
Application filed by Macef, Laboratoires Besins Iscovesco filed Critical Macef
Publication of SK13852000A3 publication Critical patent/SK13852000A3/sk
Publication of SK284387B6 publication Critical patent/SK284387B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SK1385-2000A 1998-03-17 1999-03-17 Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom SK284387B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/042,990 US6048868A (en) 1994-09-14 1998-03-17 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products
PCT/IB1999/000494 WO1999047521A1 (en) 1998-03-17 1999-03-17 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
SK13852000A3 SK13852000A3 (sk) 2001-09-11
SK284387B6 true SK284387B6 (sk) 2005-02-04

Family

ID=21924862

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1385-2000A SK284387B6 (sk) 1998-03-17 1999-03-17 Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom

Country Status (24)

Country Link
EP (1) EP1064284B1 (zh)
JP (1) JP4333036B2 (zh)
CN (1) CN1115342C (zh)
AR (1) AR018767A1 (zh)
AT (1) ATE215087T1 (zh)
AU (1) AU752364B2 (zh)
BG (1) BG63973B1 (zh)
BR (1) BR9908833A (zh)
CA (1) CA2324270A1 (zh)
DE (1) DE69901098T2 (zh)
DK (1) DK1064284T3 (zh)
ES (1) ES2174632T3 (zh)
HU (1) HUP0101234A3 (zh)
IL (1) IL138442A (zh)
IS (1) IS2199B (zh)
NO (1) NO317296B1 (zh)
NZ (1) NZ506913A (zh)
PL (1) PL193450B1 (zh)
PT (1) PT1064284E (zh)
RU (1) RU2210571C2 (zh)
SK (1) SK284387B6 (zh)
TR (1) TR200003596T2 (zh)
UA (1) UA71911C2 (zh)
WO (1) WO1999047521A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824829B1 (fr) * 2001-05-16 2005-06-03 Macef Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament
FR2904973A1 (fr) * 2006-08-18 2008-02-22 Fourtillan Snc Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique.
FR2916200A1 (fr) * 2007-05-18 2008-11-21 Fourtillan Snc Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique
EP2240481A1 (en) 2008-01-11 2010-10-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
US8629158B2 (en) 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003005A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
FI130627B (en) * 2021-03-31 2023-12-18 Equinorm Ltd NEW HETEROCYCLIC COMPOUNDS AND THEIR USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283343A (en) * 1987-08-17 1994-02-01 Whitby Research, Inc. 2-aryl substituted N-acetyltryptamines and process of preparing such
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
SK13852000A3 (sk) 2001-09-11
NO317296B1 (no) 2004-10-04
BG104768A (en) 2001-05-31
AU752364B2 (en) 2002-09-19
CN1299361A (zh) 2001-06-13
IL138442A0 (en) 2001-10-31
DE69901098D1 (de) 2002-05-02
UA71911C2 (en) 2005-01-17
NO20004638L (no) 2000-11-16
JP2002506867A (ja) 2002-03-05
IS5627A (is) 2000-09-12
AR018767A1 (es) 2001-12-12
NZ506913A (en) 2003-07-25
PT1064284E (pt) 2002-09-30
HUP0101234A3 (en) 2002-12-28
ES2174632T3 (es) 2002-11-01
NO20004638D0 (no) 2000-09-15
CN1115342C (zh) 2003-07-23
IS2199B (is) 2007-02-15
RU2210571C2 (ru) 2003-08-20
DK1064284T3 (da) 2002-07-22
EP1064284A1 (en) 2001-01-03
IL138442A (en) 2006-12-10
JP4333036B2 (ja) 2009-09-16
WO1999047521A1 (en) 1999-09-23
ATE215087T1 (de) 2002-04-15
EP1064284B1 (en) 2002-03-27
HUP0101234A2 (hu) 2001-12-28
BG63973B1 (bg) 2003-08-29
AU3270799A (en) 1999-10-11
CA2324270A1 (en) 1999-09-23
DE69901098T2 (de) 2002-11-21
TR200003596T2 (tr) 2001-04-20
BR9908833A (pt) 2000-11-21
PL342929A1 (en) 2001-07-16
PL193450B1 (pl) 2007-02-28

Similar Documents

Publication Publication Date Title
EP1925617B1 (en) Heterocyclic compound, and production process and use thereof
JP4051712B2 (ja) 新規メラトニン作用性のβ−カルボリン誘導体とナフタレン構造を含むその類似物、それらの製造方法および医薬品としての用途
JP4061658B2 (ja) 薬剤として有用なメラトニンおよびその類似物のアシル化誘導体
US5464781A (en) Amino naphthyridine compounds as anti-rhoumatic agents
HRP970478A2 (en) Indazole derivatives
US5801183A (en) Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
JP2010523725A (ja) 皮膚疾患処置用ホスホジエステラーゼ阻害剤としてのトリアゾロピリジン
BG64052B1 (bg) Заместени индазолови производни и тяхното използване като инхибитори на фосфодиестераза (рdе) тип iv и на произвеждането на туморен некрозен фактор (tnf)
CA2737483A1 (en) Indole derivatives as crth2 receptor antagonists
EP0172096A1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
SK284387B6 (sk) Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom
JP2006503875A (ja) 抗痛覚過敏剤として有用なキナゾリノン誘導体
EP0154220A2 (en) Pyrazolopyridine derivatives
JPH0412270B2 (zh)
US4767755A (en) 3-(acylaminomethyl)imidazo[1,2-a]pyridine derivatives and pharmaceutical compositions
US4996213A (en) Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions
US4110455A (en) 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepines
JP2023538524A (ja) スプライシングを調節する組成物
TWI659022B (zh) 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物
WO2007124544A1 (en) Integrase inhibitors - 1
NO162188B (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazokinoliner.
WO2019082940A1 (ja) リアノジン受容体阻害薬
CZ20003279A3 (cs) Uspávači beta karbolinové deriváty, způsob jejich přípravy a použití v lékařství
MXPA00009139A (en) HYPNOTIC&bgr;-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
US4207322A (en) 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110317